A carregar...
Explanations for the high potency of HPV prophylactic vaccines
HPV L1 virus-like particle (VLP) vaccines administered in a prime/boost series of three injections over six months have demonstrated remarkable prophylactic efficacy in clinical trials and effectiveness in national immunization programs with high rates of coverage. There is mounting evidence that th...
Na minha lista:
| Publicado no: | Vaccine |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Science
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6035892/ https://ncbi.nlm.nih.gov/pubmed/29325819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.12.079 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|